Media center
PMI Press Office
The PMI Press Office responds exclusively to press inquiries. For any other matter, please use the relevant contact listed under Other queries, just to the right.
International press inquiriesDavid Fraser | U.S. press inquiriesCorey Henry |
|---|
Other queries
For questions about our products and services, please contact your nearest PMI office. Alternatively, you can get in touch with us directly.
For Job Applications
The PMI Media Center does not accept job applications and queries relating to job opportunities at Philip Morris International. Please do not send confidential or other personal information to our Press Office. You may view our job application process and search for available roles that you can apply for on our Careers page.
Latest press releases
698 Press Releases Found
- Philip Morris International Reports 2024 Third-Quarter & First Nine-Months Results; Raises 2024 Guidance for Reported Diluted EPS to $6.20 - $6.26 and Adjusted Diluted EPS to $6.45 - $6.51
- Court-Appointed Mediator Proposes CCAA Plan to Resolve Tobacco Product-Related Claims and Litigation in Canada
- Philip Morris International to Host Webcast of 2024 Third-Quarter and First Nine-Months Results
- Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
Resource center
-
Sweden Could Become The First Country To Leave Cigarettes Behind For Good - Factsheet
-
Delivering a Smoke-Free Future - Factsheet
-
The Problem With Burning - Factsheet
-
Nicotine What Is It and Why Is It In Smoke-free Alternatives - Factsheet
-
The Importance of Harm Reduction and Need For Better Alternatives - Factsheet
-
Japan Progress Towards A Smoke-free Future - Factsheet
-
Enable Acesss To Information
-
Good Conversion Practices
-
Our Smoke-Free Products Are For Adult Smokers Who Would Otherwise Continue To Smoke
-
Regulation Should Adapt With, and Foster Innovation
-
Smoke-Free Alternatives Some Facts
-
Smoke-Free Products Deserve Appropriate and Risk-Proportionate Regulation
-
PMI 2021 Sustainability Materiality Report
-
KPMG EU Illicit cigarette consumption report 2021 results
-
PMI ESG KPI Protocol
-
PMI Corporate - Illicit Trade - illicit trade prevention - Factsheets - Jan 2022
-
Carbon Neutrality Declaration
-
ALP Anniversary Report December 2021
-
Letter from PMI’s CFO to International Shareholder Services, Inc. (ISS) dated September 6th, 2021
-
PMI Low-Carbon Transition Plan Executive Summary
-
PMI's Environmental Commitment
-
Who's afraid of a scientist?
-
André Calantzopoulos Boston CEO Club Speech 03.05.2019
-
PMI Supports Objectives of EU SUP Directive
-
Global Goals Yearbook 2019 - PMI
-
PMI Comments on FDA ANPRM - Flavors
-
![icoTransition]()
22.1 million
smokers who have switched to IQOS**
-
![icoMoney]()
35.1
billion USD net revenues
-
![icoGlove]()
738.2
billion units total shipment volume
-
![icoLight]()
50
production facilities
Galleries
54
Videos
Video
8 Videos Found
Discover who we are
* Figure includes Swedish Match and Vectura Fertin Pharma.
** As of June 30, 2024, PMI estimates that approximately 22.1 million adults around the world had already switched to IQOS and stopped smoking. IQOS user metrics reflect PMI estimates, which are based on consumer claims and sample-based statistical assessments with an average margin of error of +/-5% at a 95% Confidence Interval in key volume markets. The accuracy and reliability of IQOS user metrics may vary based on individual market maturity and availability of information.